Works by Johansen, Per Wiik

Results: 7

Fra ketobemidon til morfin eller oksykodon.

Published in:

Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2016, v. 136, n. 18, p. 1518, doi. 10.4045/tidsskr.16.0510

By:

Ræder, Johan;
Dahl, Vegard;
Markestad, Anne;
Nordbø, Arve;
Roaldset, Anne Hilde;
Stubhaug, Audun;
Søeberg, Bjørn;
Willke, Anke;
Aasbø, Vidar;
Johansen, Per Wiik

Publication type:

Article

Nyttig og nødvendig om nye antikoagulasjonsmidler.

Published in:

Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2016, v. 136, n. 18, p. 1505, doi. 10.4045/tidsskr.16.0786

By:

Opdal, Mimi Stokke;
Johansen, Per Wiik

Publication type:

Article

Odd Brørs.

Published in:

Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2024, v. 144, n. 1, p. 70

By:

Opdahl, Mohammad Nouri Sharikabad Mimi Stokke;
Johansen, Per Wiik;
Myhr, Kirsten;
Sager, Georg;
Narum, Sigrid;
Gustavsen, Ingebjørg Gussgard;
Muan, Berit;
Buajordet, Ingebjørg;
Melien, Øyvind

Publication type:

Article

Thyrotrophin-releasing hormone receptor 1 and prothyrotrophin-releasing hormone mRNA expression in the central nervous system are regulated by suckling in lactating rats.

Published in:

European Journal of Endocrinology, 2005, v. 152, n. 5, p. 791, doi. 10.1530/eje.1.01902

By:

se-Karine Fjeldheim;
Per Ivar Hvring;
Ole-Petter Lseth;
Per Wiik Johansen;
Joel C Glover;
Vilborg Matre;
Ole Kristoffer Olstad;
Sjur Reppe;
Jan O Gordeladze;
S Ivar Walaas;
Kaare M Gautvik

Publication type:

Article

Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 71, n. 2, p. 254, doi. 10.1111/j.1365-2125.2010.03827.x

By:

Narum, Sigrid;
Solhaug, Vigdis;
Myhr, Kirsten;
Johansen, Per Wiik;
Brørs, Odd;
Kringen, Marianne Kristiansen

Publication type:

Article

Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype<sup>*</sup>.

Published in:

Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 333, doi. 10.1067/mcp.2002.127396

By:

Molden, Espen;
Johansen, Per Wiik;
Bøe, Grethe Helen;
Bergan, Stein;
Christensen, Hege;
Rugstad, Hans Erik;
Rootwelt, Helge;
Reubsaet, Leon;
Lehne, Gustav

Publication type:

Article

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction.

Published in:

Thrombosis Journal, 2008, v. 6, p. 1, doi. 10.1186/1477-9560-6-7

By:

Foss Haug, Kari Bente;
Sharikabad, Mohammad N.;
Kringen, Marianne K.;
Narum, Sigrid;
Sjaatil, Stine T.;
Johansen, Per Wiik;
Kierulf, Peter;
Seljeflot, Ingebjørg;
Arnesen, Harald;
Brørs, Odd

Publication type:

Article